Global Cervical Cancer Screening Market

Shankar Hanamghar29 May, 2020Health

The global cervical cancer screening market is estimated to be driven by growing prevalence of cervical cancer patients in less developed countries. According to Globocan, 19.3 million new cases of cervical cancer are estimated each year by 2026. Out of these, 85% of patients are from less developed countries. Initiatives taken by the Centers for Disease Control and Prevention (CDC) with other global health institutes to promote cervical cancer screening programs in less developed countries boost the growth opportunity of the market in these countries.